Prophylactic immunomodulatory therapy

Drug identity checked against registry records

A drug appearing in a clinical trial does not mean it is FDA-approved. Check the original regulatory source for any approval claim.

Included trials

TrialSponsorPhaseStatusPrimary completion
Study of DNL126 in Pediatric Participants With Mucopolysaccharidosis Type IIIA (Sanfilippo Syndrome Type A)NCT06181136DNLIPhase 1, Phase 2Recruiting2032-07Estimated

Regulatory dates and decisions

No regulatory events match this view.This does not mean no FDA events have occurred.